Compare Payoneer Global Inc (PAYO) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Payoneer Global Inc vs Koninklijke Philips NV — how do they compare? Payoneer Global Inc trades at $7.13 (market cap $2.41B), while Koninklijke Philips NV trades at $26.3 (market cap $25.89B). The key difference: Koninklijke Philips NV is far larger — about 10.7× Payoneer Global Inc's market cap, and Koninklijke Philips NV pays a 3.81% dividend while Payoneer Global Inc pays none. Which is the better fit depends on your goals.
| PAYO | PHG | |
|---|---|---|
Market Cap | $2.41B | $25.89B |
Sector | Technology | Health |
52-Week High | $7.42 | $32.91 |
52-Week Low | $4.27 | $25.02 |
Enterprise Value | $2.15B | $32.18B |
Dividend Yield | — | 3.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Payoneer Global (PAYO) trades at $7.12, unchanged on the day, with a bullish technical signal driven by moving averages. The company reported Q1 2026 EPS of $0.06, beating expectations, but faces scrutiny over its proposed acquisition by Nuvei for $7.40 per share. Revenue grew to $821 million in 2025, though net income fell to $73 million. Analyst consensus is 60% buy with a $8.20 price target, suggesting moderate upside from current levels.
The outlook is mixed: the acquisition offers a near-term floor but may undervalue growth potential. Risks include integration challenges and earnings volatility. Upside depends on execution of expansion initiatives like the new India tech hub. Investors should weigh acquisition certainty against long-term standalone value.
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
